4.4 Article

Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications

期刊

UROLOGY
卷 148, 期 -, 页码 224-229

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2020.08.054

关键词

-

资金

  1. National Cancer Institute [P30CA047904]
  2. Henry L. Hillman Foundation
  3. Shadyside Hospital Foundation
  4. University of Pittsburgh O'Brien Cooperative Research Center Program [U54-DK112079]
  5. National Cancer Institute Cancer Center Support Grant [P30 CA047904]

向作者/读者索取更多资源

The study found that big chain pharmacies charged significantly more for generic BPH medications to uninsured patients compared to independent pharmacies, but independent pharmacies demonstrated more regional price variation.
OBJECTIVE To examine the geographic and pharmacy-type variation in costs for generic benign prostatic hyperplasia (BPH) medications in order to improve drug price transparency and reduce health disparities. Medical therapy for BPH can be expensive, having significant implications for uninsured and underinsured patients. METHODS We generated a 20% random sample of all pharmacies in Pennsylvania and queried each for the uninsured cash price of a 3 0-day prescription of tamsulosin 0.4mg daily, finasteride 5mg daily, oxybutynin immediate release 5mg TID and oxybutynin XL 10mg daily. Our primary objectives were to identify price variation based on pharmacy type (i.e., big chain and independent) and between geographic regions (predetermined by the Pennsylvania Health Care Cost Containment Council Database). We fit multivariable quantile regression models to test for an association between drug price and region after controlling for pharmacy type. RESULTS Among 575 retail pharmacies contacted, 473 responded (82% response rate). The median cash price was significantly higher for big chain pharmacies than for independent pharmacies for tamsulosin ($66 vs. $15), finasteride ($68 vs. $15), oxybutynin immediate release ($49 vs. $35), and oxybutynin XL ($79 vs. $31) (all p < 0.05). When controlling for region, the median and 75th percentile price of all drugs was significantly higher for big chain pharmacies. When controlling for pharmacy type, regional variation was noted in all four drugs at the 75th percentile price and was greater for independent pharmacies. CONCLUSION Compared to independent pharmacies, big chain pharmacies charged significantly more for generic BPH medications to uninsured patients. However, independent pharmacies demonstrated more regional variation in their pricing. (c) 2020 Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据